ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,066Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 2680

$1.1M Total Retail Price of All Prescriptions

Rank: 45 out of 2680

419 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 661 548 1 4
LISINOPRIL 572 481 2 5
MIRTAZAPINE 462 336 3 48
DONEPEZIL HCL 443 373 4 28
DIVALPROEX SODIUM 409 245 5 90
FUROSEMIDE 383 254 6 7
CITALOPRAM HBR 383 276 6 22
METOPROLOL TARTRATE 365 282 8 8
JANTOVEN 329 259 9 81
NAMENDA 316 245 10 43
OMEPRAZOLE 314 183 11 2
POLYETHYLENE GLYCOL 3350 287 202 12 55
AMLODIPINE BESYLATE 273 195 13 3
LEVETIRACETAM 250 157 14 94
GABAPENTIN 235 103 15 21
SANTYL 220 64 16 144
METFORMIN HCL 219 130 17 6
RISPERIDONE 214 145 18 67
QUETIAPINE FUMARATE 191 115 19 72
HYDROCODONE-ACETAMINOPHEN 178 141 S3 20 13
POTASSIUM CHLORIDE 168 98 21 29
NYSTATIN-TRIAMCINOLONE 151 72 22 140
SERTRALINE HCL 149 98 23 23
SPIRIVA 145 99 24 36
LIDOCAINE HCL 144 108 25 251
RANITIDINE HCL 138 84 26 35
CLOZAPINE 137 26 27 226
BACLOFEN 114 27 28 123
CYMBALTA 103 45 29 56
PREDNISONE 102 59 30 45
PAROXETINE HCL 101 74 31 62
METHADONE HCL 99 47 S2 32 201
CARVEDILOL 96 69 33 27
SEROQUEL 94 66 34 161
TRAZODONE HCL 86 51 35 60
TAMSULOSIN HCL 85 55 36 25
IBUPROFEN 83 22 37 63
VALPROIC ACID 82 62 38 221
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 35 39 137
PERMETHRIN 78 48 40 307
METOPROLOL SUCCINATE 77 74 41 11
OXCARBAZEPINE 75 0 42 382
ISOSORBIDE MONONITRATE ER 74 67 43 57
DIOVAN 73 65 44 26
HYDROCHLOROTHIAZIDE 73 71 44 9
CARBAMAZEPINE 73 61 44 184
SIMVASTATIN 69 63 47 1
PRAVASTATIN SODIUM 66 44 48 16
PLAVIX 65 63 49 41
METOCLOPRAMIDE HCL 62 39 50 150
PHENYTOIN SODIUM EXTENDED 61 29 51 207
CRESTOR 59 31 52 15
CEFTRIAXONE 58 25 53 272
HYDRALAZINE HCL 57 29 54 99
LANTUS 57 20 54 70
CLONIDINE HCL 56 39 56 84
OXYBUTYNIN CHLORIDE ER 55 31 57 135
ATENOLOL 55 37 57 14
LIDODERM 55 35 57 74
CARBIDOPA-LEVODOPA 54 23 60 88
NITROGLYCERIN PATCH 54 49 60 171
DIGOXIN 53 53 62 59
AVONEX 50 12 63 565
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.